Rexahn Pharmaceuticals, Inc. (RNN)
|
0.4979
+0.0254 (+5.38%)
|
|
|
|
RNN additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
RNN Profile
•
Exchange
AMEX
•
Held by these Mutual Funds
•
Executives
Dr. Chang H. Ahn Ph.D.
Founder
Chairman Chief Exec. Officer and Chief Science Officer
Mr. Rakesh Soni
Pres and Chief Operating Officer
Dr. Stephen M. Stahl M.D. .D.
Consultant
Dr. Madhukar H. Trivedi M.D. r>Consultant
Founder
Chairman Chief Exec. Officer and Chief Science Officer
Mr. Rakesh Soni
Pres and Chief Operating Officer
Dr. Stephen M. Stahl M.D. .D.
Consultant
Dr. Madhukar H. Trivedi M.D. r>Consultant
•
Index Membership
N/A
•
Employee Count
15
Special Offers
Competitors
RNN earnings
No earnings releases available.
